Researchers at Sutter's California Pacific Medical Center (CPMC) in San Francisco, Calif. have identified potential new ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the ...

Witness the mesmerizing journey of a sunflower's growth in our captivating time-lapse video, "Growing Sunflower Time-lapse Part 1: Seed to Day 30." This video captures every critical stage, showcasing ...

Discover investment opportunities in Rezolute, Inc. as new drug ersodetug advances in phase 3 HI trials, with catalysts ...

(GLOBE NEWSWIRE) -- (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an ...

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company is in the process of addressing comments received by the U.S. Food and Drug Administration (FDA) in connection ...

Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of solid tumors Discovery of unique combination of cytokines in mult ...

编者按：近年来，寡核苷酸类药物凭借其直接调控基因表达的独特机制，在中枢神经系统（CNS）疾病治疗领域展现出巨大潜力，受到业内广泛关注。迄今为止，美国FDA已批准多款寡核苷酸药物用于CNS疾病的治疗，如脊髓性肌萎缩症（SMA）和肌萎缩侧索硬化症（ALS ...

During the second quarter of 2025, the largest portfolio sector weightings were Information Technology and Financials. Read ...

EVERLAST-A Phase 2a trial enrollment ongoing with data expected 2H 2026 MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) - ...

Are you preparing for UPSC CSE 2026? Sharpen your Mains answer-writing skills with GS-3 questions. Thought process and answer ...